SS-31 – 50mg

$200.00

SS-31 helps improve mitochondrial function and overall production of energy via ATP synthesis. Research has shown its ability to reduce inflammatory cytokines which cause oxidative stress and inflammatory diseases such as Alzheimer’s, Parkinson’s, heart disease, diabetes, kidney disease, and more

SKU: sm05220 Categories: ,
Description

SS-31 – 50mg

SS-31 helps improve mitochondrial function and overall production of energy via ATP synthesis. Research has shown its ability to reduce inflammatory cytokines which cause oxidative stress and inflammatory diseases such as Alzheimer’s, Parkinson’s, heart disease, diabetes, kidney disease, and more

Benefit

  • Improved Mitochondrial Function: SS-31 may help enhance mitochondrial function, leading to increased cellular energy production and improved overall cell health.
  • Neurological Benefits: Some studies suggest that SS-31 may protect neurons from damage and improve cognitive function, potentially benefiting individuals with neurodegenerative disorders.
  • Cardiovascular Benefits: SS-31’s potential cardioprotective effects may reduce the risk of heart-related conditions and improve cardiovascular function.
  • Anti-Aging Properties: Mitochondrial dysfunction is associated with aging, and SS-31’s ability to protect mitochondria has led to speculation about its potential anti-aging effects.

Disclaimer

The information provided above is not intended to substitute medical advice, diagnosis, or treatment. Should you have any questions regarding a medical condition, seek the advice of your physician or a qualified healthcare provider. In no case should medical advice be disregarded or delayed because of what you have read or seen. We bear no responsibility or liability for your use of any of our research compounds and products. Please note that they are being sold for research purposes ONLY. We do NOT condone any personal use.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “SS-31 – 50mg”

Your email address will not be published. Required fields are marked *